Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
582.00    3.00 (0.52%)
Bid:
581.00
Ask:
583.00
Spread: 2.00 (0.344%)
Market Cap: £846.17m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Director/PDMR Shareholding

16 Oct 2020 07:00

RNS Number : 2675C
SAGA PLC
16 October 2020
 

SAGA PLC (THE "COMPANY") - DIRECTOR/PDMR SHAREHOLDING(S)

Pursuant to the notification obligations under Article 19 of the Market Abuse Regulation, the Company hereby notifies the following changes in the interests of directors and persons discharging managerial responsibility ("PDMRs") in Ordinary Shares in the Company ("Shares").

 

16 October 2020

Capitalised terms not otherwise defined in this announcement have the meanings given to them in the Company's announcement of the launch of the Capital Raising on 10 September 2020.

Adjustments to options and awards under share schemes

On 2 October 2020, the Company announced that the Open Offer for qualifying shareholders to acquire New Shares in the Company at 12 pence per share had closed on 30 September 2020 in accordance with its terms.

Certain Directors and PDMRs of the Company hold awards of, or options to acquire, Ordinary Shares under certain Company share schemes. Pursuant to the notification obligations under Article 19 of the Market Abuse Regulation, the Company wishes to confirm the interests of its directors and PDMRs following the Open Offer and related adjustments to options and awards under its share schemes.

Open Offer related adjustment to options and awards

Name

Options subject to performance conditions

Options NOT subject to performance conditions

Pre- Open Offer

Post- Open Offer

Pre- Open Offer

Post- Open Offer

Cheryl Agius1

-

-

1,636,594

1,797,044

Stuart Beamish

639,777

702,500

750,987

824,613

Julius Christmas

667,667

733,125

738,732

811,157

James Quin1

1,660,682

1,823,493

1,803,578

1,980,399

Nick Stace

-

-

554,323

608,668

Jane Storm

594,059

652,300

765,227

840,249

Euan Sutherland1

1,353,965

1,486,706

2,803,720

3,078,595

Helen Webb

242,416

266,182

470,025

516,106

1 director

The interests of the directors and PDMRs immediately following the share consolidation of 1 Consolidated Share of 15 pence each for every 15 Existing Ordinary Shares of 1 pence each are set out below:

Impact of consolidation of existing shareholdings

Name

Interest in shares - pre- consolidation

Interest in shares - post- consolidation

Cheryl Agius1

148,412

9,894

Stuart Beamish

915

61

Julius Christmas

1,439

95

Sir Roger De Haan1

552,833,333

36,855,555

Eva Eisenschimmel1

64,328

4,288

Julie Hopes1

66,293

4,419

Gareth Hoskin1

210,276

14,018

Orna NiChionna1

45,414

3,027

James Quin1

222,388

14,825

Euan Sutherland1

395,086

26,339

Helen Webb

722

48

Gareth Williams1

68,159

4,543

1 director

Consolidation-related adjustment to options and awards

Name

Options subject to performance conditions

Options NOT subject to performance conditions

Pre-consolidation

Post- consolidation

Pre-consolidation

Post- consolidation

Cheryl Agius1

-

-

1,797,044

119,801

Stuart Beamish

702,500

46,833

824,613

54,972

Julius Christmas

733,125

48,873

811,157

54,077

James Quin1

1,823,493

121,566

1,980,399

132,025

Nick Stace

-

-

608,668

40,577

Jane Storm

652,300

43,486

840,249

56,016

Euan Sutherland1

1,486,706

99,113

3,078,595

205,238

Helen Webb

266,182

17,745

516,106

34,406

1  director

 

Contact:

Vicki Haynes

Company Secretary

Telephone:  01303 771199

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFETIFLELII
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
24th Oct 20247:35 amRNSDirector Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.